SCHEMBL7702205

SCHEMBL7702205

CCNC(=O)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
MAPT P10636 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
KDM4E B2RXH2 1/20 0.59
HTT P42858 1/20 0.59
KMT2A Q03164 6/20 0.58
MEN1 O00255 4/20 0.58
LMNA P02545 1/20 0.54
HPGD P15428 1/20 0.53
GLA P06280 1/20 0.52
EPHX2 P34913 1/20 0.50
CYP17A1 P05093 1/20 0.50
CYP19A1 P11511 1/20 0.50
HSD11B1 P28845 1/20 0.49
POLB P06746 1/20 0.49
ITGB1 P05556 1/20 0.49
ITGA4 P13612 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24758464 0.89 ALDH1A1 (0.50) ALDH1A1MAPTSMN1; SMN2KDM4EHTT
SCHEMBL13895393 0.83 PKM (0.48) ALDH1A1MAPTSMN1; SMN2KDM4EHTT
SCHEMBL14388437 0.82 PKM (0.47) ALDH1A1MAPTSMN1; SMN2KDM4EHTT
SCHEMBL25039172 0.82 SMN1; SMN2 (0.49) ALDH1A1MAPTSMN1; SMN2KDM4EHTT
SCHEMBL17702625 0.81 KMT2A (0.70) ALDH1A1SMN1; SMN2KDM4EHTTKMT2A
SCHEMBL9260496 0.80 KDM4E (0.56) ALDH1A1KDM4EHTTKMT2AMEN1
SCHEMBL5858380 0.79 MEN1 (0.57) ALDH1A1KDM4EHTTKMT2AMEN1
SCHEMBL13840110 0.79 SMN1; SMN2 (0.57) ALDH1A1SMN1; SMN2KDM4EHTTKMT2A
SCHEMBL16064957 0.79 HTT (0.54) ALDH1A1KDM4EHTTKMT2AMEN1
SCHEMBL8591629 0.79 KDM4E (0.54) ALDH1A1MAPTSMN1; SMN2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110423216-A A kind of 2- (1- adamantane formamido) methylcarbamoyl ethyl esters compound and its preparation method and application UNIV ZHEJIANG TECHNOLOGY 2019-11-08 CN claimed
US-6348625-B1 TREATING CORRESPONDING CARBOXYLIC ACID FUNCTIONAL GROUP WITH N,N-DIETHYL-1,1,2,3,3,3-HEXAFLUOROPROPYLAMINE FOLLOWED BY AMMONIA ANDERSON GLORIA LONG (US) 2002-02-19 US claimed
US-12540245-B2 Water repellent composition, method for producing water repellent composition, and fiber product MITSUI CHEMICALS, INC. (JP) 2026-02-03 US disclosed
CN-112437783-B Non-fluorinated block copolymers 大金工业株式会社 2023-08-25 CN disclosed
EP-4223764-A1 AMIDE COMPOUND Daikin Industries, Ltd. (JP) 2023-08-09 EP disclosed
EP-4219572-A1 GRAFT POLYMER Daikin Industries, Ltd. (JP) 2023-08-02 EP disclosed
US-20230227596-A1 GRAFT POLYMER DAIKIN INDUSTRIES LTD. (JP) 2023-07-20 US disclosed
US-20230220140-A1 AMIDE COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2023-07-13 US disclosed
CN-116396451-A Non-fluorinated block copolymers 大金工业株式会社 2023-07-07 CN disclosed
US-20230037578-A1 WATER REPELLENT COMPOSITION, METHOD FOR PRODUCING WATER REPELLENT COMPOSITION, AND FIBER PRODUCT DAIKIN INDUSTRIES, LTD. (JP) 2023-02-09 US disclosed
EP-4083078-A1 WATER REPELLENT COMPOSITION, METHOD FOR PRODUCING WATER REPELLENT COMPOSITION, AND TEXTILE PRODUCT Mitsui Chemicals, Inc. (JP) 2022-11-02 EP disclosed
US-20170059992-A1 RESIST PATTERN-FORMING METHOD AND CHEMICALLY AMPLIFIED RADIATION-SENSITIVE RESIN COMPOSITION JSR CORPORATION (JP) 2017-03-02 US disclosed
US-20160327866-A1 PATTERN FORMING METHOD, TREATING AGENT, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING THE SAME FUJIFILM CORPORATION (JP) 2016-11-10 US disclosed
US-20160195814-A1 PATTERN FORMATION METHOD, ELECTRONIC-DEVICE PRODUCTION METHOD, AND PROCESSING AGENT FUJIFILM CORPORATION (JP) 2016-07-07 US disclosed
US-20160116840-A1 COMPOUND, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, RESIST FILM USING SAME, RESIST-COATED MASK BLANK, PHOTOMASK, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2016-04-28 US disclosed
US-20160041465-A1 PATTERN FORMING METHOD, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, RESIST FILM, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2016-02-11 US disclosed
US-20160011517-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, METHOD OF MANUFACTURING ELECTRONIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2016-01-14 US disclosed
US-20110165512-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2011-07-07 US disclosed
US-20110165512-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2011-07-07 US disclosed
US-6348625-B1 TREATING CORRESPONDING CARBOXYLIC ACID FUNCTIONAL GROUP WITH N,N-DIETHYL-1,1,2,3,3,3-HEXAFLUOROPROPYLAMINE FOLLOWED BY AMMONIA ANDERSON GLORIA LONG (US) 2002-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160116840-A1 COMPOUND, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, RESIST FILM USING SAME, RESIST-COATED MASK BLANK, PHOTOMASK, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE CHRM1, ESR1, RER1 ALDH1A1 3574/4885MAPT 1842/4885SMN1; SMN2 2930/4885
US-20230227596-A1 GRAFT POLYMER GMNN, FIBP, FASN ALDH1A1 1867/4885MAPT 3042/4885SMN1; SMN2 1908/4885
US-12540245-B2 Water repellent composition, method for producing water repellent composition, and fiber product AFF1, RER1, NAF1 ALDH1A1 1894/4885MAPT 914/4885SMN1; SMN2 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.